AXIM Biotechnologies has developed a second-generation version of its rapid neutralising antibody test for Covid-19. The new test shows whether the user has responded to the Covid-19 vaccine in just ten minutes. It also delivers a semi-quantitative analysis of their neutralising antibody levels. Currently being analysed by the US Food and Drug Administration (FDA), the original test measures levels of functional neutralising antibodies that are thought to prevent SARS-CoV-2 from entering host cells.
Nutriband has entered an agreement with US-based Diomics to manufacture the Diocheck Transdermal Test, a visual Covid-19 antibody indicator patch. Leveraging the FDA-cleared Diomat bioresorbable polymer of Diomics, the test checks and reports if an individual has developed a circulating level of Covid-19 specific antibodies in 24 to 36 hours. A positive response leads to a change in colour of the skin, visible through the Diocheck skin patch.
Singapore’s Health Sciences Authority has granted approval to medical technology company Lucira Health’s LUCIRA CHECK IT COVID-19 Test Kit through its pandemic special access route. The self-test can be carried out anywhere, any time and delivers laboratory-quality molecular results in just 30 minutes after obtaining the sample. The company also collaborated with Labgistics Asia to import and supply the test to the region.